Canada
· Delayed Price · Currency is CAD CareRx Statistics
Total Valuation
CareRx has a market cap or net worth of CAD 140.73 million. The enterprise value is 226.57 million.
| Market Cap | 140.73M |
| Enterprise Value | 226.57M |
Important Dates
The next estimated earnings date is Thursday, August 8, 2024.
| Earnings Date | Aug 8, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
CareRx has 60.14 million shares outstanding. The number of shares has increased by 17.43% in one year.
| Shares Outstanding | 60.14M |
| Shares Change (YoY) | +17.43% |
| Shares Change (QoQ) | +2.07% |
| Owned by Insiders (%) | 1.71% |
| Owned by Institutions (%) | 35.98% |
| Float | 28.34M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 43.90 |
| PS Ratio | 0.37 |
| PB Ratio | 1.72 |
| P/FCF Ratio | 5.16 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.51, with an EV/FCF ratio of 8.31.
| EV / Earnings | -60.05 |
| EV / Sales | 0.61 |
| EV / EBITDA | 8.51 |
| EV / EBIT | 29.39 |
| EV / FCF | 8.31 |
Financial Position
The company has a current ratio of 1.05, with a Debt / Equity ratio of 119.28.
| Current Ratio | 1.05 |
| Quick Ratio | 0.70 |
| Debt / Equity | 119.28 |
| Debt / EBITDA | 3.65 |
| Debt / FCF | 3.56 |
| Interest Coverage | 0.59 |
Financial Efficiency
Return on equity (ROE) is -4.73% and return on invested capital (ROIC) is 2.46%.
| Return on Equity (ROE) | -4.73% |
| Return on Assets (ROA) | 1.93% |
| Return on Capital (ROIC) | 2.46% |
| Revenue Per Employee | 236,736 |
| Profits Per Employee | -2,420 |
| Employee Count | 1,685 |
| Asset Turnover | 1.48 |
| Inventory Turnover | 13.21 |
Taxes
| Income Tax | -440,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +5.41% in the last 52 weeks. The beta is 0.90, so CareRx's price volatility has been similar to the market average.
| Beta (5Y) | 0.90 |
| 52-Week Price Change | +5.41% |
| 50-Day Moving Average | 2.21 |
| 200-Day Moving Average | 1.84 |
| Relative Strength Index (RSI) | 59.20 |
| Average Volume (20 Days) | 6,437 |
Short Selling Information
The latest short interest is 865, so 0.00% of the outstanding shares have been sold short.
| Short Interest | 865 |
| Short Previous Month | 1,548 |
| Short % of Shares Out | 0.00% |
| Short % of Float | 0.00% |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CareRx had revenue of CAD 369.07 million and -3.77 million in losses. Loss per share was -0.06.
| Revenue | 369.07M |
| Gross Profit | 105.54M |
| Operating Income | 7.71M |
| Pretax Income | -7.96M |
| Net Income | -3.77M |
| EBITDA | 22.88M |
| EBIT | 7.71M |
| Loss Per Share | -0.06 |
Balance Sheet
The company has 11.37 million in cash and 97.21 million in debt, giving a net cash position of -85.85 million or -1.43 per share.
| Cash & Cash Equivalents | 11.37M |
| Total Debt | 97.21M |
| Net Cash | -85.85M |
| Net Cash Per Share | -1.43 |
| Equity (Book Value) | 81.50M |
| Book Value Per Share | 1.36 |
| Working Capital | 3.28M |
Cash Flow
In the last 12 months, operating cash flow was 31.59 million and capital expenditures -4.31 million, giving a free cash flow of 27.28 million.
| Operating Cash Flow | 31.59M |
| Capital Expenditures | -4.31M |
| Free Cash Flow | 27.28M |
| FCF Per Share | 0.45 |
Margins
Gross margin is 28.60%, with operating and profit margins of 2.09% and -1.02%.
| Gross Margin | 28.60% |
| Operating Margin | 2.09% |
| Pretax Margin | -2.16% |
| Profit Margin | -1.02% |
| EBITDA Margin | 6.20% |
| EBIT Margin | 2.09% |
| FCF Margin | 7.39% |
Dividends & Yields
CareRx does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -17.43% |
| Shareholder Yield | -17.43% |
| Earnings Yield | -2.76% |
| FCF Yield | 19.38% |
Stock Splits
The last stock split was on June 25, 2020. It was a reverse split with a ratio of 0.05.
| Last Split Date | Jun 25, 2020 |
| Split Type | Reverse |
| Split Ratio | 0.05 |